Introduction {#S1}
============

Familial Mediterranean fever (FMF) is known as the most common hereditary autoinflammatory disease, which had been first genetically described \[[@ref1]\]. Most of the patients had biallelic MEFV gene mutations, which is located in chromosome 16, and the disease-causing effects of these mutations were firstly defined in 1997.

In FMF patients, MEFV mutations are suggested to alter functions of the pyrin, commonly expressed in neutrophils, and thus lead to elevated amounts of interleukin 1 (IL-1) and inflammation \[[@ref1], [@ref2]\].

Patients with FMF, characterized by recurrent inflammation and serositis attacks lasting 1--3 days, usually present with fever, abdominal pain, arthralgia, chest pain and erysipelas-like erythema \[[@ref3]\].

Colchicine is commonly prescribed to alleviate the frequency and severity of the symptoms and prevent the most common devastating complication, renal amyloidosis. Besides, some patients still require anti-IL-1 agents because of the colchicine resistance and intolerance \[[@ref4], [@ref5]\].

In recent years, the diet has been suggested to play an important role in the pathogenesis of multifactorial autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus (SLE) \[[@ref6]--[@ref8]\]. Besides, we have recently showed an increased frequency of functional gastrointestinal disorders in FMF patients \[[@ref9]\].

However, relevant literature lacks studies determining the effects of dietary habits on symptoms and treatment outcomes in FMF patients currently. Therefore, we aimed to investigate the dietary behavior and self-efficacy of children with FMF and the relation with symptoms, attack frequency, and treatment outcomes.

Material and methods {#S2}
====================

Participants {#S2_1}
------------

This retrospective cross-sectional study was performed in FMF patients, aged between 10--18 years and admitted to our department between June 2019 and September 2019. All patients were diagnosed according to Tel-Hashomer clinical criteria by the same pediatric rheumatologists and received colchicine treatment since their diagnosis \[[@ref10]\].

Medical data including demographic properties, symptoms, laboratory results, MEFV gene analysis results, treatment and outcomes were obtained from the files of the patients retrospectively. Colchicine dosage, annual attack frequency and disease severity scores, established with Tel-Hashomer severity scoring system were also recorded \[[@ref11]\].

Acute Phase Reactants (APRs), including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and serum amyloid A (SAA) were obtained at the time of study enrollment. A complete response to colchicine was defined as having no attack during last year.

The study was approved by the Bioethical Committee at Cukurova University Faculty of Medicine.

Questionnaires {#S2_2}
--------------

Dietary self-efficacy and behavior were assessed according to the Children's Dietary Self-Efficacy Scale (CDSS) and Health Behavior Questionnaire (HBQ) -- Diet Behavior Scale (DBS), covered by Child and Adolescent Trial for Cardiovascular Health (CATCH) trial \[[@ref12]\].

Children's Dietary Self-Efficacy Scale questions the self-confidence about preferring less salty and fatty meals in their regular diets, rather than more salty and fatty meals. This scale consists of 15 items and was scored as --1 (not sure), 0 (a little sure) and 1 (very sure) for each item. Dietary behavior scale (DBS) consisted of 14 pictorial sub-items that make the participants choose a higher fat and higher sodium food or lower fat and lower sodium food. Each item was scored as --1 for unhealthy food and +1 for healthy food \[[@ref13]\].

Both scales were self-administered in routine outpatient visit and the scores of CDSS and DBS were ranged between --15 and +15, --14 and +14, respectively. Cut-off value for the sum of these two scores was considered as 5. These scales were previously validated in Turkish children and relevant permission was obtained for this study from the corresponding investigators \[[@ref13]\].

Statistical analysis {#S2_3}
--------------------

Categorical variables are measured as numbers and percentages, besides quantitative variables were analyzed as mean and standard deviation or median and minimum--maximum where appropriate.

Kolmogorov-Smirnov test was used for testing the distribution of the variables. Student *t*-test and Mann-Whitney *U*-tests were performed for comparison of quantitative variables, according to the distribution pattern. Spearman rho correlation coefficient was utilized while investigating the correlation between two continuous, abnormal distributed variables. Multivariate logistic regression analysis was utilized for determining the risk factors for a complete response to colchicine.

Statistical analysis was exerted by SPSS 20.0 statistical software package (IBM SPSS Statistics). The significance level for all tests was considered to be 0.05.

Results {#S3}
=======

The mean age of the 74 patients (44 females, 34 males) was 14.6 ±2.82 years at study enrollment. Median follow-up time was 37.8 (range, 12--133) months. Parental consanguinity and family history of FMF were present in 23 (31.1%) and 32 (43.2%) of the patients, respectively. The demographic and clinical features of the patients were summarized in [Table I](#T1){ref-type="table"}.

###### 

Main demographic and clinical features of the children with familial Mediterranean fever

  Parameters                                 *n* (%)
  ------------------------------------------ -------------------
  Age at symptom onset, year (mean ±SD)      5.01 ±3.41
  Age at diagnosis, year (mean ±SD)          9.04 ±3.38
  Age at study enrollment, year (mean ±SD)   14.58 ±2.82
  Gender, F/M                                44/30 (59.5/40.5)
  Parental consanguinity                     23 (31.1)
  Family history of FMF                      32 (43.2)
  Recurrent fever                            67 (90.5)
  Abdominal pain                             69 (93.2)
  Arthralgia                                 48 (64.9)
  Arthritis                                  15 (20.3)
  Chest pain                                 3 (4.1)
  Myalgia                                    2 (2.7)
  Diarrhea                                   6 (8.1)
  Splenomegaly                               3 (4.1)
  Erysipelas-like erythema                   6 (8.1)
  Proteinuria                                2 (2.7)
  Complete response to colchicine            58 (78.4)
  Total number of patients                   74 (100)

FMF -- familial Mediterraneanfever, SD -- standard deviation.

While investigating the distribution of MEFV mutations, we found that 18 (24.3%) of the patients had M694V homozygosity ([Table II](#T2){ref-type="table"}). Median CDSS and DBS scores were 5 (minimum --6, maximum 14) vs. 0 (minimum --10, maximum 12), respectively. There was a low-degree positive correlation between CDSS and DBS scores (*r* = 0.374, *p* = 0.001). CDSS and DBS were scored at least 0 (zero) in 59 (79.7%) and 34 (45.9%) of the patients.

###### 

Distribution of MEFV genotype in children with familial Mediterranean fever

  MEFV genotype   Number (*n*)   Percent (%)
  --------------- -------------- -------------
  M694V/M694V     18             24.3
  M694V/R202Q     11             14.9
  M694V/V726A     4              5.4
  M694V/E148Q     2              2.7
  M694V/R761H     2              2.7
  M694V/M680I     2              2.7
  M694V/K695R     1              1.4
  M694V/--        2              2.7
  M680I/M680I     2              2.7
  M680I/E148Q     1              1.4
  M680I/--        4              5.4
  M694I/M694I     1              1.4
  V726A/V726A     1              1.4
  V726A/R761H     1              1.4
  V726A/E148Q     1              1.4
  V726A/--        1              1.4
  E148Q/E148Q     3              4.1
  E148Q/R202Q     2              2.7
  E148Q/--        5              5.4
  Total           74             100

FMF -- familial Mediterraneanfever, MEFV -- Mediterraneanfevergenotype.

When these two scores were summed-up, the patients were grouped according to a cut-off total score of 5. Regarding that, 39 (52.7%) patients had self-efficacy and behaviors about healthy (less salty or less fatty) dietary meals. Demographic and clinical features were compared between these two groups in [Table III](#T3){ref-type="table"}. While demographic parameters, symptoms, attack frequency, colchicine dosage, disease severity and Acute Phase Reactants (APRs), including ESR, CRP and SAA were similar, complete response to colchicine was higher in FMF patients preferring less salty or less fatty meals.

###### 

Comparison of main demographic and clinical features between children with familial Mediterranean fever according to their dietary self-efficacy and habits about preference of salty and fatty meals

  Parameters                                   Total score of dietary self-efficacy and behavior scales   p                   
  -------------------------------------------- ---------------------------------------------------------- ------------------- ---------
  Age at symptom onset (year), mean ±SD        4.72 ±3.28                                                 5.26 ±3.55          0.505
  Age at diagnosis (year), mean ±SD            9.40 ±3.63                                                 8.72 ±3.16          0.397
  Age at study enrollment (year), mean ±SD     14.56 ±3.14                                                14.59 ±2.25         0.956
  Gender, F/M, *n* (%)                         19/16 (54.3/45.7)                                          25/14 (64.1/35.9)   0.479
  Recurrent fever, *n* (%)                     33 (94.3)                                                  34 (87.2)           0.435
  Abdominal pain, *n* (%)                      34 (97.1)                                                  35 (89.7)           0.361
  Arthralgia, *n* (%)                          26 (74.3)                                                  22 (56.4)           0.145
  Arthritis, *n* (%)                           8 (22.9)                                                   7 (17.9)            0.773
  Chest pain, *n* (%)                          1 (2.9)                                                    2 (5.1)             0.541
  Diarrhea, *n* (%)                            3 (8.6)                                                    3 (7.7)             0.609
  Complete response to colchicine, *n* (%)     23 (65.7)                                                  35 (89.7)           0.022\*
  Colchicine dosage (mg/day), median (range)   1 (0.5--2)                                                 1 (0.5--1.5)        0.084
  Disease severity score, median (range)       6 (4--10)                                                  6 (4--11)           0.920
  Attack frequency per year, median (range)    0 (0--12)                                                  0 (0--24)           0.101
  ESR (mm/h), median (range)                   14 (2--47)                                                 18 (2--68)          0.881
  CRP (mg/l), median (range)                   2.2 (1--79.7)                                              2.5 (1--90.6)       0.223
  SAA (mg/l), median (range)                   4.1 (2.9--763)                                             5.3 (2.8--349)      0.698

CRP -- C-reactive protein, ESR -- erythrocytesedimentationrate, FMF -- familial Mediterraneanfever, SAA -- serum amyloid A, SD -- standard deviation, Student t-test and Mann-Whitney U-testswereutilized for comparison of demographic and laboratory data, respectively, \* significant p-values (\< 0.05).

[Table IV](#T4){ref-type="table"} indicated the results of multivariate logistic regression analysis of risk factors for complete response to colchicine, which showed the significance of the total dietary score on complete response to colchicine.

###### 

Multivariate logistic regression analysis of risk factors for complete response to colchicine

  Risk factor                    Regression coefficient   Standard error   Wald    *p*       OR      95% CI of OR   
  ------------------------------ ------------------------ ---------------- ------- --------- ------- -------------- --------
  Gender                         --0.111                  0.692            0.026   0.873     0.895   0.230          3.476
  Age at symptom onset           0.185                    0.105            3.107   0.078     1.203   0.980          1.477
  Age at diagnosis               --0.051                  0.101            0.254   0.614     0.950   0.779          1.159
  Fever                          0.729                    1.385            0.277   0.599     2.073   0.137          3.126
  Abdominal pain                 0.606                    1.681            0.130   0.719     1.833   0.068          4.942
  Arthralgia                     1.086                    0.816            1.770   0.183     2.962   0.598          14.667
  Arthritis                      0.272                    1.021            0.071   0.790     1.312   0.177          9.713
  M694V homozygosity             --0.379                  0.906            0.175   0.676     0.684   0.116          4.043
  Total score ≥ 5 (CDSS + DBS)   1.512                    0.682            4.919   0.027\*   0.220   0.058          0.839
  Constant                       --3.108                  2.452            1.607   0.205                            

CDSS -- Children's Dietary Self-Efficacy Scale, CI -- confidenceinterval, DBS -- Diet Behavior Scale, OR -- odds ratio, \* significant p-values.

Discussion {#S4}
==========

In the present study, we found a statistically significant higher rate of complete colchicine response in patients with a preference of less salty or fatty meals. Besides, the symptoms and laboratory results did not differ between patients grouped according to their dietary self-efficacy and behavior. There are only a few ancient studies investigating the role of dietary fat consumption in FMF and none for dietary salt intake in FMF patients.

Firstly, in 1961, Mellinkoff et al. \[[@ref14]\] suggested that low-fat diet greatly reduced the incidence of fever attacks in 8 patients with FMF. They also discovered that there was a close relationship between dietary indiscretions and prompt exacerbations. However, it was obvious why low-fat diet did improve the disease course in FMF patients in that study \[[@ref14]\].

One year later, Sohar et al. \[[@ref15]\] commenced a therapeutic trial on 32 colchicine-naïve FMF patients, of which 8 of them did not complete the regimen due to the belief of ineffectiveness. The authors concluded that a low-fat diet did not have an impact on the frequency of FMF attacks. Colchicine became the gold standard treatment option and no other studies have been carried for clarifying a beneficial effect of diet on FMF. Since then, the role of diet on FMF has been underestimated.

However, during recent years, diet and gut microbiota have been suggested to act as an important factor on pathogenesis and courses of several autoimmune diseases. Dietary intake of vitamin A, D, E, polyunsaturated fatty acids and phytoestrogens have been proposed to have an appositive impact on SLE \[[@ref7]\].

Robinson et al. \[[@ref16]\] recently showed that the majority of SLE patients did not have talked to their health professionals about diet, however again the majority of them also believed that diet can be important in controlling disease symptoms \[[@ref16]\].

On the other hand, although FMF pathogenesis had been enlightened with the presence of autosomal recessive inheritance pattern, patients even with low penetrance mutations in MEFV gene, heterozygote disease -- causing mutations or no mutations have been seldom diagnosed with FMF \[[@ref17]\].

By this point, without any evidence, diversity of genotype led us to think that there may be several environmental factors which effect the pathogenesis and the course of FMF. However, dietary factors have not been investigated in FMF patients to the best of our knowledge so far.

Recently, an experimental study suggested that higher salt intake results in the differentiation of T helper (Th) cells to proinflammatory Th17 subtypes \[[@ref8], [@ref18]\]. Another study also revealed that salt leads to epigenetic changes including DNA demethylation in Th cells and thus causes autoimmunity \[[@ref19]\]. Higher salt concentration was also related to excessive secretion of proinflammatory cytokines from macrophages, overactivation in dendritic cells and overexpression of IL-1β \[[@ref20]\].

Overall, these studies all proposed a low-grade inflammation theory in salty microenvironment. Therefore, although we could not demonstrate a bench-to-bedside clarification, we showed that complete colchicine response was statistically higher in patients with a higher self-efficacy and better behavior on preferring lower salty and fatty meals. We speculate that lower salt intake may alleviate the inflammatory state and lead to better disease courses in FMF patients.

On the other hand, it is an area of interest whether dietary fat and carbohydrate content have an impact on inflammation \[[@ref21]\]. A relevant study did reveal higher plasma IL-6 and tumor necrosis factor-alpha (TNF-α) levels after a meal rich in saturated fatty acids, and lower plasma levels of the same cytokines after a meal rich in polyunsaturated fatty acids \[[@ref22]\]. Another study showed that fat-rich meals, regardless of the type of fatty acids, lead to elevated IL-6 but have no impact on TNF-α \[[@ref23]\].

These studies also suggested that a fatty diet may be linked to an inflammatory state similar to the results of our preliminary study. Although APRs did not differ between patients in terms of dietary behavior and self-efficacy, this result may be due to the small number of the patients and the lack of quantitative measurement of salt and fat in the meals.

There is much more need for more comprehensive studies on this topic for clarifying the impact of high-fat diet consuming on inflammation in FMF patients. Limitations of our study include a small number of participants and the lack of experimental bench-to-bedside study design. However, we think that our observational study will precede further researches on this topic.

Conclusions {#S5}
===========

In conclusion, dietary self-efficacy and behavior on a low-salt or fat intake are linked to higher rates of complete colchicine response. We think that dietary low-salt and fat may alleviate the low-grade inflammation and might be an important modification adjuvant to standard treatment in FMF patients. There is an ongoing need for further studies for clarifying the role of diet on the pathogenesis and course of FMF, which have been underestimated so far.
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